Alpha 2.0
Login Register
» Authors » Csaba Siffel

Csaba Siffel

Explore the profile of Csaba Siffel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 1297
Followers 0
Related Specialties
Genetics
Pediatrics
General Medicine
Top 10 Co-Authors
Adolfo Correa
Pierpaolo Mastroiacovo
Annukka Ritvanen
Lorenzo D Botto
Guido Cocchi
R Brian Lowry
Eduardo E Castilla
Gioacchino Scarano
Elena Szabova
Sujata P Sarda
Published In
Birth Defects Res A Clin Mol Teratol
Am J Med Genet C Semin Med Genet
Pediatrics
Am J Med Genet A
J Matern Fetal Neonatal Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Real-World Effectiveness, Safety, and Tolerability of Facilitated Subcutaneous Immunoglobulin 10% in Secondary Immunodeficiency Disease: A Systematic Literature Review
Dimou M, Vacca A, Sanchez-Ramon S, Karakulska-Prystupiuk E, Lionikaite V, Siffel C, et al.
J Clin Med . 2025 Feb; 14(4). PMID: 40004732
: Secondary immunodeficiency disease (SID) is a complex, heterogeneous condition that occurs when extrinsic factors weaken the immune system. Expert consensus guidelines recommend immunoglobulin replacement therapy to manage immunoglobulin G...
2.
A Systematic Literature Review on the Global Status of Newborn Screening for Mucopolysaccharidosis II
Ayodele O, Fertek D, Evuarherhe O, Siffel C, Audi J, Yee K, et al.
Int J Neonatal Screen . 2024 Oct; 10(4). PMID: 39449359
A systematic literature review was conducted to determine the global status of newborn screening (NBS) for mucopolysaccharidosis (MPS) II (Hunter syndrome; OMIM 309900). Electronic databases were searched in July 2023...
3.
Comprehensive literature review of protein C concentrate use in patients with severe congenital protein C deficiency
Siffel C, Wadhwa A, Tongbram V, Ogongo M, Sliwka H, Gazda H, et al.
Res Pract Thromb Haemost . 2024 Sep; 8(6):102542. PMID: 39286606
Severe congenital protein C deficiency (SCPCD) is a rare disorder associated with life-threatening purpura fulminans and disseminated intravascular coagulation that typically present within hours after birth. Treatment options for patients...
4.
Treatment patterns and burden of infection in patients with chronic lymphocytic leukemia and secondary immunodeficiency: a retrospective database study
Siffel C, Richter J, Anderson-Smits C, Kamieniak M, Ren K, Shah D, et al.
Ann Hematol . 2024 Sep; 103(11):4567-4580. PMID: 39264434
Patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and secondary immunodeficiency disease (SID) are susceptible to severe, recurrent, or persistent infections. This retrospective cohort study assessed the burden of infection...
5.
Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell Malignancy
Richter J, Davids M, Anderson-Smits C, Kamieniak M, Ren K, Hull M, et al.
Clin Lymphoma Myeloma Leuk . 2024 May; 24(8):553-563. PMID: 38734499
Background: This retrospective cohort study compared patient characteristics and burden of infection in patients with mature B cell malignancies with and without secondary immunodeficiency disease (SID). Patients And Methods: Data...
6.
Assessing the potential of polygenic scores to strengthen medical risk prediction models of COVID-19
Cordova-Palomera A, Siffel C, DeBoever C, Wong E, Diogo D, Szalma S
PLoS One . 2023 May; 18(5):e0285991. PMID: 37235597
As findings on the epidemiological and genetic risk factors for coronavirus disease-19 (COVID-19) continue to accrue, their joint power and significance for prospective clinical applications remains virtually unexplored. Severity of...
7.
The clinical burden of extremely preterm birth in a large medical records database in the United States: complications, medication use, and healthcare resource utilization
Siffel C, Hirst A, Sarda S, Chen H, Ferber J, Kuzniewicz M, et al.
J Matern Fetal Neonatal Med . 2022 Sep; 35(26):10271-10278. PMID: 36170979
Introduction: Approximately 5% of global preterm births are extremely premature (EP), defined as occurring at less than 28 weeks gestational age. Advances in care have led to an increase in...
8.
Long-term burden of respiratory complications associated with extreme prematurity: An analysis of US Medicaid claims
Mowitz M, Gao W, Sipsma H, Zuckerman P, Wong H, Ayyagari R, et al.
Pediatr Neonatol . 2022 Jul; 63(5):503-511. PMID: 35817695
Background: Infants born extremely premature (EP) (<28 weeks gestational age) are at high risk of complications, particularly bronchopulmonary dysplasia (BPD), which can develop into chronic lung disease (CLD). Methods: The...
9.
The clinical burden of extremely preterm birth in a large medical records database in the United States: Mortality and survival associated with selected complications
Siffel C, Hirst A, Sarda S, Kuzniewicz M, Li D
Early Hum Dev . 2022 Jul; 171:105613. PMID: 35785690
Background: Preterm birth is a leading cause of infant mortality, particularly for those born extremely prematurely (EP; <28 weeks' gestational age [GA]). Survivors are predisposed to complications such as bronchopulmonary...
10.
Respiratory morbidity, healthcare resource use, and cost burden associated with extremely preterm birth in The Netherlands
Houben E, Siffel C, Overbeek J, Penning-van Beest F, Niklas V, Sarda S
J Med Econ . 2021 Oct; 24(1):1290-1298. PMID: 34709122
Background: Extremely preterm (EP) infants have high rates of respiratory morbidity and correspondingly high healthcare resource utilization. Objectives: Data from the PHARMO Perinatal Research Network were analyzed to quantify the...